Antithrombin deficiency patient registry
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study is a registry that collects information about people with antithrombin deficiency, a rare blood disorder that increases the risk of blood clots. By joining, you help doctors learn more about the condition and improve care for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of antithrombin deficiency, either through a genetic test or through blood tests that show the deficiency.
- If you have the genetic diagnosis, you're eligible even if the exact gene change hasn't been identified yet.
- This study is a registry, so you'll be asked to share your medical information and history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at patient records to see how antithrombin (a medicine that helps prevent blood clots) was used in intensive care or during surgery. It does not test a new treatment, but helps doctors understand if the medicine was given appropriately.
This trial tests whether Atenativ (an antithrombin treatment) lowers dangerous blood clots during planned surgery or during late pregnancy/delivery. It’s for people with a rare inherited blood-clotting condition called congenital antithrombin deficiency.
This study is a national registry that collects medical information from people diagnosed with a type of blood-clotting disorder called acquired TTP (aTTP). It may help researchers better understand the disease and how it’s managed, without necessarily changing your treatment.
This study collects health information from people who have alpha-1 antitrypsin deficiency. It may help doctors better understand the condition and improve care over time.
This study builds a registry by asking adults who take blood thinners (anticoagulants) about their experiences. It may help improve care by learning how these medicines are used in real life.
This trial builds a database to study patterns in blood tests and blood smear findings that can suggest small blood clots in the body. Joining may help researchers learn how to recognize and track these changes over time.
Hear when a new Antithrombin III Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.